1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Peripheral circulatory conditions

PROPATEN heparin-bonded vascular graft for peripheral arterial disease

Medtech innovation briefing [MIB42] Published: 13 October 2015

  • Overview
  • Summary
  • Introduction
  • Technology overview
  • Evidence review
  • Relevance to NICE programmes
  • References
  • Search strategy and evidence selection
  • Summary of medical device reports
  • Appendix
  • About this briefing
Download (PDF)

Advice

  • Next

Relevance to NICE programmes

Relevance to NICE programmes

NICE has issued the following guidance or advice:

  • Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease (2011) NICE technology appraisal guidance 223

  • Endovascular stent-grafting of popliteal aneurysms (2011) NICE interventional procedure guidance 390

  • Lower limb peripheral arterial disease: diagnosis and management (2012) NICE guideline CG147

  • Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices (2011) NICE interventional procedure guidance 380

  • Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease (2012) NICE interventional procedure guidance 433

  • Spiral Flow peripheral vascular graft for treating peripheral arterial disease (2015) NICE Medtech innovation briefing 34


  • Next